(Q43736405)

26 November 2017

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease (English)

1 reference

26 November 2017

0 references

1

Wyss-Coray T

1 reference

26 November 2017

7

Mucke L

1 reference

26 November 2017

2

Masliah E

1 reference

26 November 2017

Mallory M

3

1 reference

26 November 2017

McConlogue L

series ordinal

4

1 reference

26 November 2017

Johnson-Wood K

series ordinal

5

1 reference

26 November 2017

Lin C

series ordinal

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

26 November 2017

1 reference

26 November 2017

389

1 reference

26 November 2017

603-606

1 reference

26 November 2017

6651

1 reference

https://scigraph.springernature.com/pub.10.1038/39321

26 November 2017

0 references

cites work

Alzheimer's disease: a central role for amyloid

1 reference

7 January 2021

Exploring the etiology of Alzheimer disease using molecular genetics

1 reference

7 January 2021

Amyloid, the presenilins and Alzheimer's disease

1 reference

7 January 2021

TGF-beta 1 is an organizer of responses to neurodegeneration

1 reference

7 January 2021

Transforming growth factor beta: a matter of life and death

1 reference

7 January 2021

Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.

1 reference

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

7 January 2021

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease

1 reference

7 January 2021

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

1 reference

7 January 2021

Cerebral amyloid angiopathy. A critical review

1 reference

7 January 2021

Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease.

1 reference

7 January 2021

Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease

1 reference

7 January 2021

Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly.

1 reference

7 January 2021

Apolipoprotein E and Alzheimer's disease

1 reference

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

7 January 2021

Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives

1 reference

7 January 2021

Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury.

1 reference

7 January 2021

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

1 reference

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

7 January 2021

Spectrum of human immunodeficiency virus-associated neocortical damage

1 reference

7 January 2021

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

1 reference

7 January 2021

Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits

1 reference

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

7 January 2021

Identifiers

DOI

10.1038/39321

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference